PWM
ABEO icon

Palumbo Wealth Management’s Abeona Therapeutics ABEO Stock Holding History

Palumbo Wealth Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,368
Closed -$104K – 152
2024
Q1 		$104K Buy
+14,368
New +$91.1K 0.05% 129

Other funds holding ABEO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Palumbo Wealth Management's ABEO Position: Q2 2024 in Review

Palumbo Wealth Management sold out of Abeona Therapeutics (ABEO) in Q2 2024, closing a stake of 14,368 shares — an estimated $104K sold.

Palumbo Wealth Management first reported a position in ABEO in Q1 2024 and held it in 1 quarter. The position peaked at $104K in Q1 2024. 48 funds tracked by Wall St. Rank hold ABEO as of Q2 2024.

  • Palumbo Wealth Management reported no remaining Abeona Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Palumbo Wealth Management sold 14,368 Abeona Therapeutics shares in Q2 2024, an estimated $104K.
  • Palumbo Wealth Management first reported a position in Abeona Therapeutics in Q1 2024 and held it in 1 quarter.
  • Palumbo Wealth Management's Abeona Therapeutics position peaked at $104K in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2024.

Based on Palumbo Wealth Management's 13F filing for Q2 2024, filed 2 Aug 2024.